Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MSTR | Class A Common Stock | Options Exercise | $130K | +10K | +201.21% | $12.96 | 15K | Mar 25, 2025 | Direct | |
transaction | MSTR | Class A Common Stock | Options Exercise | $66.5K | +5K | +33.4% | $13.29 | 20K | Mar 25, 2025 | Direct | |
transaction | MSTR | Class A Common Stock | Sale | -$2.41M | -7.2K | -36.05% | $335.31 | 12.8K | Mar 25, 2025 | Direct | F1 |
transaction | MSTR | Class A Common Stock | Sale | -$2.56M | -7.6K | -59.51% | $336.42 | 5.17K | Mar 25, 2025 | Direct | F2 |
transaction | MSTR | Class A Common Stock | Sale | -$67.4K | -200 | -3.87% | $337.15 | 4.97K | Mar 25, 2025 | Direct | |
holding | MSTR | Class A Common Stock | 20K | Mar 25, 2025 | By Meredithe Rechan 2021 Family Trust |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MSTR | Director Stock Option (Right to buy) | Options Exercise | $0 | -10K | -100% | $0.00 | 0 | Mar 25, 2025 | Class A Common Stock | 10K | $12.96 | Direct | F3 |
transaction | MSTR | Director Stock Option (Right to buy) | Options Exercise | $0 | -5K | -20% | $0.00 | 20K | Mar 25, 2025 | Class A Common Stock | 5K | $13.29 | Direct | F4 |
Id | Content |
---|---|
F1 | The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $335.00 to $335.70, inclusive. The reporting person undertakes to provide to MicroStrategy Incorporated d/b/a Strategy ("Strategy"), any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. |
F2 | The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $336.00 to $336.91, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. |
F3 | The 10,000 shares exercised on March 25, 2025 pursuant to this option vested on May 31, 2022. |
F4 | The 5,000 shares exercised on March 25, 2025 pursuant to this option vested on May 31, 2022. Of the remaining 20,000 shares subject to this option, 7,500 shares vested on May 31, 2022, and 12,500 vested on May 31, 2023. |
Exhibit 24 - Power of Attorney